ASEAN Health Screening market, By Test Type (Cholesterol Tests, Diabetes Test, Cancer Tests, General Check Up Test, STD's, Blood Pressure Test, and Others), Application (Cardiovascular Disease, Metabolic Disorders, Oncology, Inflammatory Conditions, Musculoskeletal Disorders, Neurological Conditions, Hepatitis-C Complications, Immunology-Related Conditions, and Others), Panel Type (Multi-Test Panels, Single-Test Panels), Care/Facility (Integrated, Standalone), User (Domestic User, Medical Tourist), Customer Income (Upper Class, Medium Class, and Lower Class), Provider (Hospitals, Clinics, Nursing Facilities, Rehabilitation Centers, Diagnostic Laboratories, and Others), Countries (India, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Cambodia, Brunei, Burma and Laos) - Industry Trends and Forecast to 2031.
ASEAN Health Screening Market Analysis and Insights
In October 2023, according to the event named as “International Day of Older Persons in Asia and the Pacific, 2023” published on Economic and Social Commission for Asia and the Pacific region. In 2023, an estimated 697 million older persons (60 years or over) are residing in Asia and the Pacific, representing about 60 per cent of all older persons in the world. Roughly one in 7 persons in the region are currently 60 years or older, and by 2050, there will be one in 4 persons belonging to this age cohort. Women account for about 54 per cent of all older women. With increasing age, their share increases. Thus, women account for most of all older persons in the region. Population ageing in Asia and the Pacific is particularly rapid, given the decline in fertility and mortality over recent years. This translates into limited time to prepare for the impacts of ageing on societies.
Data Bridge Market Research analyzes that the Asean health screening market is expected to reach USD 47,078.82 million by 2031 from USD USD 17,697.22 million in 2023, growing at a CAGR of 13.5% in the forecast period of 2024 to 2031.
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016–2021)
|
|
Quantitative Units
|
Revenue in USD Million
|
|
Segments Covered
|
Test Type (Cholesterol Tests, Diabetes Test, Cancer Tests, General Check Up Test, STD's, Blood Pressure Test, and Others), Application (cardiovascular Disease, Metabolic Disorders, Oncology, Inflammatory Conditions, Musculoskeletal Disorders, Neurological Conditions, Hepatitis-C Complications, Immunology-Related Conditions, and Others), Panel Type (Multi-Test Panels, Single-Test Panels), Care/Facility (Integrated, Standalone), User (Domestic User, Medical Tourist), Customer Income (Upper Class, Medium Class, and Lower Class), Provider (Hospitals, Clinics, Nursing Facilities, Rehabilitation Centers, Diagnostic Laboratories, and Others), Countries (India, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Cambodia, Brunei, Burma, and Laos)
|
|
Countries Covered
|
India, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Cambodia, Brunei, Burma and Laos
|
|
Market Players Covered
|
Fullerton Health Corporation Limited, Mount Alvernia Hospital, PT Prodia Widyahusada Tbk, Raffles Medical Group, and Icon Group, among others
|
Market Definition
Health screening is an important tool for detecting a disease early on. Screening tests are frequently used in preventative medicine to determine whether a person displays early indicators of a condition's risk factors. Cancer, diabetes, high cholesterol, high blood pressure, and osteoporosis are all diseases that can be discovered by screening.
This market encompasses a wide range of activities, including routine health check-ups, specialized screenings for chronic diseases such as diabetes, cancer, and cardiovascular conditions, as well as advanced diagnostic procedures. It also involves the use of medical technology and equipment to conduct these tests, and often includes health management programs aimed at promoting overall wellness and early intervention. The health screening market is driven by increasing public awareness of preventive care, advancements in diagnostic technology, and growing demand for personalized healthcare solutions.
ASEAN Health Screening Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Driver
- Increasing Geriatric Population
The increasing geriatric population in the ASEAN region is a key driver for the health screening market. For example, in 2020, 13.6 percent of the population in Asia and the Pacific is aged 60 years or over, by 2050 it will be one quarter of the population. Health screening plays a crucial role in this context by offering routine check-ups, diagnostic tests, and screenings for various health conditions such as cardiovascular diseases, cancer, diabetes, and respiratory disorders.
While longer lifespans reflect the region’s development success, comprehensive policy reforms are urgently needed to support the welfare of older people, according to Aging Well in Asia: Asian Development Policy Report, released by the Asian Development Bank (ADB) at its 57th Annual Meeting. The number of people aged 60 and older in developing Asia and the Pacific is set to nearly double by 2050 to 1.2 billion—or about a quarter of the total population—significantly increasing the need for pension and welfare programs as well as health care services.
The demand for health screening services is further bolstered by increasing healthcare expenditures, rising disposable incomes, and a growing understanding of the benefits of proactive healthcare management among the aging population in ASEAN. As a result, the health screening market in the region is expected to continue expanding to meet the needs of the increasing geriatric demographic.
Restraint
- High Cost of Healthcare Services
The high cost of health screening services presents a significant restraint for the ASEAN health screening market. Affordability remains a key concern, particularly in low- and middle-income countries where a large portion of the population struggle to access or afford comprehensive health screenings. This economic barrier limits the widespread adoption of preventive healthcare measures and early detection services, hindering efforts to combat the rising burden of chronic diseases in the region. Addressing the issue of high costs requires collaborative efforts from governments, healthcare providers, and private sector entities to develop cost-effective screening solutions, negotiate affordable pricing structures, and implement subsidies or insurance schemes to enhance accessibility for underserved populations.
Opportunity
- Technological Advancements in Health Screening
Innovations in imaging technology, molecular diagnostics, and digital health solutions have revolutionized how diseases are detected and monitored. Technologies such as PCR-based assays, high-resolution imaging techniques, and artificial intelligence-driven analytics have improved the accuracy, speed, and accessibility of health screening tests. This not only benefits healthcare providers by enabling earlier and more precise diagnoses but also empowers patients with better understanding and management of their health.
Moreover, the introduction of these advanced technologies has created a competitive environment where companies strive to differentiate themselves through innovation. These dynamic drives continuous improvement and the development of increasingly sophisticated screening tools, ultimately expanding the overall market for health screening products and services.
Challenge
- Inadequate Quality Assurance and Control
Variations in equipment calibration, maintenance, and operator training can lead to discrepancies in diagnostic accuracy and reliability. Inconsistent calibration schedules or lack of access to calibration services can result in inaccurate readings, affecting diagnosis and treatment outcomes. Additionally, inadequate maintenance due to budget constraints or lack of skilled technicians can cause equipment malfunctions, leading to downtime and unreliable diagnostic results. The proficiency of healthcare providers in operating diagnostic equipment and conducting screening procedures varies widely, and insufficient training along with the lack of standardized protocols can lead to human errors, further compromising the quality and reliability of screenings.
Recent Developments
- In August 2022, Fullerton Health completed merger led by RRJ Capital; Stronger Balance Sheet and New Corporate Structure propelled the post-pandemic growth opportunities. Fullerton Health Corporation Limited (“Fullerton Health” or the “Company”) announced that it had completed a merger led by RRJ Capital (“RRJ”) involving an equity injection by the private equity firm and a senior loan totalling USD 390 million. The merger delivered a stronger balance sheet and a new capital structure which propelled the post-pandemic growth opportunities for the pan-Asian healthcare provider
ASEAN Health Screening Market Scope
ASEAN health screening market is segmented into eight notable segments based on test type, application, panel type, care/facility, user, customer income, provider, country. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Test Type
- Cholesterol Tests
- Diabetes Test
- Cancer Tests
- General Check Up Test
- STD's
- Blood Pressure Test
- Others
On the basis of test type, the market is segmented into cholesterol tests, diabetes test, cancer tests, general check up test, STD's, blood pressure test, and others.
Application
- Cardiovascular Disease
- Metabolic Disorders
- Oncology
- Inflammatory Conditions
- Musculoskeletal Disorders
- Neurological Conditions
- Hepatitis-C Complications
- Immunology-Related Conditions
- Others
On the basis of application, the market is segmented into cardiovascular disease, metabolic disorders, oncology, inflammatory conditions, musculoskeletal disorders, neurological conditions, hepatitis-c complications, immunology-related conditions, and others.
Panel Type
- Multi-Test Panels
- Single-Test Panels
On the basis of panel type, the market is segmented into multi-test panels and single-test panels.
Care/Facility
- Integrated
- Standalone
On the basis of care/facility, the market is segmented into integrated and standalone.
User
- Domestic User
- Medical Tourist
On the basis of user, the market is segmented into domestic user and medical tourist.
Customer Income
- Upper Class
- Medium Class
- Lower Class
On the basis of customer income, the market is segmented into upper class, medium class, and lower class.
Provider
- Hospitals
- Clinics
- Nursing Facilities
- Rehabilitation Centers
- Diagnostic Laboratories
- Others
On the basis of provider, the market is segmented into hospitals, clinics, nursing facilities, rehabilitation centers, diagnostic laboratories, and others.
ASEAN Health Screening Market Market Regional Analysis/Insights
ASEAN health screening market is segmented into eight notable segments based on test type, application, panel type, care/facility, user, customer income, provider, and country.
The countries covered in this market report is India, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Cambodia, Brunei, Burma and Laos.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and ASEAN Health Screening Market Share Analysis
ASEAN Health Screening market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
Some of the major market players operating in the market are Fullerton Health Corporation Limited, Mount Alvernia Hospital, Pt Prodia Widyahusada Tbk., Raffles Medical Group, Icon Group, and The Farrer Park company among others.
SKU-